| | | | By Helen Branswell STEFANI REYNOLDS/POOL/AFP via Getty Images The CDC will undergo an "ambitious" overhaul, Director Rochelle Walensky outlined in an email to staff Wednesday. Read More | By Allison DeAngelis STAT Dudley enjoys working across the health care space — he can talk about everything from insurance claims to CRISPR gene editing. Read More | By Adam Feuerstein Ruby Wallau for STAT Zynteglo is just the third gene therapy approved by the FDA, and the first to target a chronic blood disease. Read More | Sponsor content by Salesforce STAT E-Book: How technology shapes patient experiences Our latest e-book underscores the vast range of technologies that are shaping how patients find and receive health care, from smartphone apps to deliver therapy and bedside bots to channel medication requests to new tools to collect real-world data and wearable watches to detect heart health. These stories illustrate the exciting advances being made on these technologies and highlight the challenges to their broader adoption. Download now. | By Angus Chen Molly Ferguson for STAT With the right synthetic biomarkers, scientists may be able to find cancers earlier, tailor treatment and track progress. Read More | By Matthew Herper Wikimedia Commons The data, though inarguably positive, will lead to discussion about Ayvakit's safety and efficacy as well as Blueprint’s pricing strategy. Read More | By Ed Silverman A report finds the NIH failed to ensure that results of roughly half of clinical trials funded by the agency were reported. Read More | By Edward Chen Edward Chen/STAT How has the field of genomics changed in the past decade? STAT asked leading experts to look back and look ahead. Read More | |
No comments